Extracellular adenosine regulates colitis through effects on lymphoid and nonlymphoid cells

Area of Science:

• Immunology
• Gastroenterology
• Pharmacology

Background:

• Adenosine, a purine metabolite, exerts anti-inflammatory effects in the gut via the A(2A) adenosine receptor (A(2A)AR).
• Colitis, a form of inflammatory bowel disease, involves complex immune dysregulation in the digestive tract.

Purpose of the Study:

• To investigate the role of A(2A)AR in regulating inflammation within the context of colitis.
• To determine the specific cell types and mechanisms through which A(2A)AR influences colitis development.

Main Methods:

• Utilized an adoptive transfer model of colitis in mice, including A(2A)AR knockout (A(2A)AR(-/-)) and wild-type strains.
• Analyzed T cell subsets (helper T cells and regulatory T cells) and employed bone marrow chimeric models to assess A(2A)AR function in different cell populations.

Main Results:

• A(2A)AR(-/-) mice exhibited increased colonic inflammation following Helicobacter hepaticus infection.
• Adoptive transfer experiments indicated that A(2A)AR expression on both T cells and recipient cells is important for controlling colitis.
• Myeloid cell-specific A(2A)AR expression did not prevent colitis development, suggesting a more complex role for myeloid cells.

Conclusions:

• A(2A)AR signaling is essential for the in vivo control of colitis, involving collaboration between multiple cell types.
• Extracellular adenosine, acting through A(2A)AR, plays a critical role in regulating immune responses that prevent excessive inflammation in the digestive tract.